The aim of the project is to develop multiparametric diagnostic kits and prototypes for the determination of auto-antibodies against selected antigens, which will be applied in differential diagnosis, evaluation of disease progression and response to the treatment of selected neurological diseases – Alzheimer’s, Parkinson’s disease and other types of dementia. There are currently no commercial kits to diagnose these neurodegenerations. Developed highly specific tests will create a new segment in the global market. a.